Skip to main content
logo
Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.430
+0.100 (3.00%)
At close: Jul 2, 2026, 4:00 PM EDT
3.440
+0.010 (0.29%)
After-hours: Jul 2, 2026, 6:49 PM EDT

Niagen Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
274507411107125255
Market Cap Growth
-74.96%23.47%282.96%-14.41%-50.83%-14.22%
Enterprise Value
209.93445.01368.6183.17109.09231.27
Last Close Price
3.436.365.311.431.683.74
PE Ratio
16.3331.8048.27---
Forward PE
16.4427.8150.28---
PS Ratio
2.103.924.121.281.743.78
PB Ratio
3.326.628.913.774.378.03
P/TBV Ratio
3.827.679.073.844.188.14
P/FCF Ratio
66.6738.3734.3715.39--
P/OCF Ratio
61.8437.5433.9115.07--
EV/Sales Ratio
1.613.443.701.001.513.43
EV/EBITDA Ratio
17.5233.9843.16---
EV/EBIT Ratio
18.9136.1447.71---
EV/FCF Ratio
51.1333.6830.8611.94--
Debt / Equity Ratio
0.020.020.040.090.120.13
Debt / EBITDA Ratio
0.220.220.31---
Debt / FCF Ratio
0.630.210.220.47--
Net Debt / Equity Ratio
-0.78-0.81-0.91-0.84-0.56-0.74
Net Debt / EBITDA Ratio
-5.34-4.73-4.925.260.920.91
Net Debt / FCF Ratio
-15.58-4.69-3.52-3.451.050.96
Asset Turnover
1.181.481.621.531.291.40
Inventory Turnover
2.103.123.212.252.072.05
Quick Ratio
3.493.742.921.581.621.90
Current Ratio
4.614.863.572.402.612.78
Return on Equity (ROE)
21.24%25.00%25.97%-17.29%-54.77%-112.68%
Return on Assets (ROA)
9.46%13.39%12.15%-10.27%-33.29%-56.29%
Return on Invested Capital (ROIC)
63.45%125.44%176.38%-66.28%-180.00%-565.55%
Return on Capital Employed (ROCE)
12.47%18.00%18.25%-15.88%-48.75%-87.18%
Earnings Yield
6.81%3.14%2.07%---
FCF Yield
1.50%2.61%2.91%6.50%--
Buyback Yield / Dilution
-7.04%-9.36%-4.19%-7.54%-3.79%-10.02%
Total Shareholder Return
-7.04%-9.36%-4.19%-7.54%-3.79%-10.02%
SEC Filings: 10-K · 10-Q